Home » Stocks » IGXT

IntelGenx Technologies Corporation (IGXT)

Stock Price: $0.5850 USD -0.0050 (-0.85%)
Updated May 10, 2021 11:46 AM EDT - Market open
Market Cap 65.90M
Revenue (ttm) 1.54M
Net Income (ttm) -7.04M
Shares Out 111.91M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $0.5850
Previous Close $0.5900
Change ($) -0.0050
Change (%) -0.85%
Day's Open 0.5830
Day's Range 0.5800 - 0.6121
Day's Volume 164,331
52-Week Range 0.1234 - 0.6900

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SAINT LAURENT, Quebec, May 12, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it has entered into a second feasib...

1 day ago - GlobeNewsWire

SAINT LAURENT, Quebec, May 11, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that a significant majority...

1 day ago - GlobeNewsWire

SAINT LAURENT, Quebec, April 09, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it is proposing to a...

1 month ago - GlobeNewsWire

SAINT LAURENT, Quebec, March 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) ("Company" or "IntelGenx") today announced that, further to its press releases of January 7 and March 25...

1 month ago - GlobeNewsWire

SAINT-LAURENT, Quebec, March 25, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter and ...

1 month ago - GlobeNewsWire

SAINT LAURENT, Quebec, March 18, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its fourth quarter and full-year 2020 f...

1 month ago - GlobeNewsWire

SAINT LAURENT, Quebec, Feb. 17, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that the United States Patent and Trademark Office (“USPTO”) has granted a...

2 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Feb. 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it has filed a new provisional patent application at the United State...

3 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Jan. 12, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (“IntelGenx” or the “Company”) today announced that its Board of Directors appointed Mr. T...

4 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Jan. 06, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Corporation” or “IntelGenx”) announced that on December 31, 2020, it issued 887,880 ...

4 months ago - GlobeNewsWire

SAINT-LAURENT, Quebec, Dec. 08, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces that it intends to issue 899,940 common shares of...

5 months ago - GlobeNewsWire

SAINT-LAURENT, Quebec, Nov. 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTCQB:IGXT) announced today that the Company's board of directors gran...

5 months ago - GlobeNewsWire

IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

SAINT LAURENT, Quebec, Nov. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Patent and T...

6 months ago - GlobeNewsWire

- Data Suggest Montelukast May Inhibit Mental Decline , Higher Doses Optimal for Clinical Trials Assessing Impact on Neurological Disease -

6 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its third quarter 2020 financial results after market...

6 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Oct. 29, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has executed a binding letter of intent (“LOI”) wi...

6 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Oct. 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) is pleased to announce that it has closed a private placemen...

6 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Oct. 21, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has entered into an amended and restated license a...

6 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Oct. 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces the closing of an offering by way of private place...

6 months ago - GlobeNewsWire

- Agreement Adds 26 Countries to Commercial Territory, with Initial Sales Expected in Early 2021-

8 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Aug. 24, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTCQB:IGXT) announced today that the Company’s board of directors am...

8 months ago - GlobeNewsWire

Intelgenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

SAINT LAURENT, Quebec, Aug. 13, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter end...

8 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, Aug. 06, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its...

9 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, July 20, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it and Tilray, Inc. (“Tilray®”) have amended the ex...

9 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, July 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) reported today, that the Company's Board of Directors ap...

9 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, July 07, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, is pleased to announce that it has entered into a fea...

10 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, June 25, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Corporation”) today announced that the holders (“Debentureholders”) ...

10 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, June 11, 2020 (GLOBE NEWSWIRE) -- Saint Laurent, Quebec, June 11, 2020 – IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today provided an update regardin...

11 months ago - GlobeNewsWire

First Purchase Order Received, with Product Availability Expected by early Q3-2020 First Purchase Order Received, with Product Availability Expected by early Q3-2020

11 months ago - GlobeNewsWire

SAINT LAURENT, Quebec, June 08, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it has received ...

11 months ago - GlobeNewsWire

Intelgenx Technologies Corp (IGXT) CEO Horst Zerbe on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

IntelGenx (IGXT) delivered earnings and revenue surprises of -50.00% and 102.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

IntelGenx (IGXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Shares of Intelgenx Technologies (OTC:IGXT) remained unaffected at $0.26 after the company reported Q4 results.

1 year ago - Benzinga

IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

IntelGenx Corp. (IGXT) resubmits NDA for Rizaport VersaFilm for the treatment of acute migraines to the FDA.

1 year ago - Zacks Investment Research

About IGXT

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/201... [Read more...]

Industry
Biotechnology
Founded
2003
CEO
Horst Zerbe
Country
Canada
Stock Exchange
OTCMKTS
Ticker Symbol
IGXT
Full Company Profile

Financial Performance

In 2020, IGXT's revenue was $1.54 million, an increase of 108.09% compared to the previous year's $742,000. Losses were -$7.04 million, -33.92% less than in 2019.

Financial Statements